Hyland’s tackles babies’ ‘unmet needs’

LOS ANGELES — Hyland’s launched Hyland’s Baby Nighttime teething tablets, a nighttime version to join its best-selling infant oral pain reliever Hyland’s Baby teething tablets in the $40 million infant oral pain segment.

(For the full report, including charts, click here.)

The new product contains no benzocaine or melatonin. Hyland’s also introduced Hyland’s Baby Calming tTablets, citing an unmet need for a natural infant product for fussiness and occasional sleeplessness. According to Hyland’s, moms are 32% more likely to give their child a calming product if it is natural.